To report a case of prolonged survival in a child with recurrent pulmonary NUT carcinoma managed with a multimodal treatment approach, highlighting its significance in the context of existing literature.
Key Findings:
The patient achieved 26 months of post-recurrence survival, exceeding the historical median survival of 6-9 months for thoracic NUT carcinoma.
Sequential multimodal treatment provided periods of disease stabilization.
Comprehensive molecular profiling may inform future therapies, particularly in rare malignancies.
Interpretation:
This case suggests that individualized multimodal management can lead to prolonged survival in recurrent pulmonary NUT carcinoma, emphasizing the importance of aggressive locoregional control and systemic therapies tailored to the patient's unique tumor profile.
Limitations:
Single case report limits generalizability and may introduce selection bias.
Lack of long-term follow-up data beyond 26 months restricts understanding of sustained outcomes.
Conclusion:
Prolonged survival in recurrent pulmonary NUT carcinoma may be achievable through tailored multimodal strategies, underscoring the importance of early intervention, comprehensive treatment planning, and the need for further research to validate these findings.
